Publication | Open Access

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirologyMedicineVaccine ResearchPhase 1Dose-escalation Clinical Trial